Since its inception in 1951, Rigaku has been at the forefront of analytical and industrial instrumentation technology. Today, with hundreds of major innovations to their credit, the Rigaku Group of Companies are world leaders in the fields of protein and small molecule X-ray crystallography, general X-ray diffraction (XRD and PXRD), X-ray spectrometry (EDXRF and WDXRF), X-ray optics, semiconductor metrology, Raman spectroscopy, laser induced breakdown (LIBS) spectrometry, automation, computed tomography, nondestructive testing, and thermal analysis.
Cement, petroleum, mining, refining, pulp and paper, wood treating, chemicals, pharmaceuticals, biotechnology, forensics, homeland security, defense, aerospace, energy, metals and alloys, life sciences, polymers and plastics, inks and dyes, cosmetics, nanomaterials, photovoltaics, semiconductors, chemistry, geology and minerals, physics, teaching, and academy.
Based in Tokyo, Japan, Rigaku is a global organization with offices, laboratories, and production facilities around the world. Major production facilities are located in Auburn Hills, Michigan; Austin, Texas; Boston, Massachusetts; Carlsbad, California; Osaka, Japan; Prague, Czech Republic; Tokyo, Japan; Wroclaw Poland ;Tucson, Arizona; The Woodlands, Texas; and Yamanashi, Japan.
Rigaku Corporation
4-14-4, Sendagaya
Tokyo 151-0051, Japan
TELEPHONE
+1(281) 362-2300
FAX
+1(281) 364-3628
E-MAILinfo@rigaku.com
WEB SITEwww.rigaku.com
NUMBER OF EMPLOYEES
Worldwide: 1400
YEAR FOUNDED
1951
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.